The Spectranetics Corp (SPNC) - Product Pipeline Analysis, 2017 Update

1 of 5

FEATURED COMPANIES

  • Abiomed Inc
  • Boston Scientific Corp
  • Utah Medical Products Inc
  • MORE
Summary

The Spectranetics Corp (Spectranetics) is a medical device company that manufactures and distributes disposable medical devices. The company provides vascular intervention, lead management and coronary intervention products. It offers peripheral and cardiac laser catheters for ablation of stenosed and occluded arteries. Spectranetics also offers coronary laser atherectomy catheters, scoring balloon catheter, excimer laser system, extraction catheter and support catheters. The company offers training and support services. It caters to physicians, patients and hospitals. The company operates in the Netherlands, France, Denmark, Germany, Austria, Australia and the UK. Spectranetics is headquartered in Colorado Springs, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company The Spectranetics Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abiomed Inc
  • Boston Scientific Corp
  • Utah Medical Products Inc
  • MORE
  • The Spectranetics Corp Company Overview
  • The Spectranetics Corp Company Snapshot
  • The Spectranetics Corp Pipeline Products and Ongoing Clinical Trials Overview
  • The Spectranetics Corp - Pipeline Analysis Overview
  • The Spectranetics Corp - Key Facts
  • The Spectranetics Corp - Major Products and Services
  • The Spectranetics Corp Pipeline Products by Development Stage
  • The Spectranetics Corp Ongoing Clinical Trials by Trial Status
  • The Spectranetics Corp Pipeline Products Overview
  • CardioSculpt Valvuloplasty Scoring Balloon
  • CardioSculpt Valvuloplasty Scoring Balloon Product Overview
  • Drug Coated Balloon - In-stent Restenosis (ISR)
  • Drug Coated Balloon - In-stent Restenosis (ISR) Product Overview
  • Nexcimer
  • Nexcimer Product Overview
  • Next Gen Lead Management (LM) Tool
  • Next Gen Lead Management (LM) Tool Product Overview
  • Next-Gen Atherectomy Device
  • Next-Gen Atherectomy Device Product Overview
  • Next-gen Mechanical Tool
  • Next-gen Mechanical Tool Product Overview
  • Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK)
  • Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) Product Overview
  • Stellarex Drug Coated Balloon - Above-The-Knee
  • Stellarex Drug Coated Balloon - Above-The-Knee Product Overview
  • Stellarex Drug Coated Balloon - Above-The-Knee Clinical Trial
  • The Spectranetics Corp - Key Competitors
  • The Spectranetics Corp - Key Employees
  • The Spectranetics Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • The Spectranetics Corp, Recent Developments
  • Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors
  • Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million
  • Feb 23, 2017: Spectranetics Reports Fourth Quarter 2016 Revenue of $71.9 million
  • Jan 24, 2017: ILLUMENATE Global 12-month Results Validate Stellarex’s Top-tier Performance in Complex Patient Populations
  • Jan 11, 2017: Spectranetics Names Scott Hutton as General Manager, Vascular Intervention
  • Nov 21, 2016: Spectranetics Receives CE Mark for Stellarex 0.014” Drug-Coated Balloon
  • Nov 02, 2016: Stellarex ILLUMENATE Pivotal Results Are Top-tier in the Most Complex Patient Group Studied in DCB IDE Trials
  • Nov 02, 2016: Spectranetics Files PMA Application for FDA Approval of the Stellarex Drug-Coated Balloon
  • Oct 27, 2016: Spectranetics Reports Third Quarter 2016 Revenue of $68.3 million
  • Aug 10, 2016: First Randomized Trial of the Stellarex Drug-coated Balloon Presented at the Amputation Prevention Symposium
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • The Spectranetics Corp Pipeline Products and Ongoing Clinical Trials Overview
  • The Spectranetics Corp Pipeline Products by Equipment Type
  • The Spectranetics Corp Pipeline Products by Indication
  • The Spectranetics Corp Ongoing Clinical Trials by Trial Status
  • The Spectranetics Corp, Key Facts
  • The Spectranetics Corp, Major Products and Services
  • The Spectranetics Corp Number of Pipeline Products by Development Stage
  • The Spectranetics Corp Pipeline Products Summary by Development Stage
  • The Spectranetics Corp Ongoing Clinical Trials by Trial Status
  • The Spectranetics Corp Ongoing Clinical Trials Summary
  • CardioSculpt Valvuloplasty Scoring Balloon - Product Status
  • CardioSculpt Valvuloplasty Scoring Balloon - Product Description
  • Drug Coated Balloon - In-stent Restenosis (ISR) - Product Status
  • Drug Coated Balloon - In-stent Restenosis (ISR) - Product Description
  • Nexcimer - Product Status
  • Nexcimer - Product Description
  • Next Gen Lead Management (LM) Tool - Product Status
  • Next Gen Lead Management (LM) Tool - Product Description
  • Next-Gen Atherectomy Device - Product Status
  • Next-Gen Atherectomy Device - Product Description
  • Next-gen Mechanical Tool - Product Status
  • Next-gen Mechanical Tool - Product Description
  • Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) - Product Status
  • Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) - Product Description
  • Stellarex Drug Coated Balloon - Above-The-Knee - Product Status
  • Stellarex Drug Coated Balloon - Above-The-Knee - Product Description
  • Stellarex Drug Coated Balloon - Above-The-Knee - Economic Evaluation Comparing Standard Balloon Angioplasty Versus Drug-eluted Balloon or Laser-excimer in Association with Drug-eluted Balloon in the Treatment of Femoropopliteal Artery In-stent Restenosis
  • Stellarex Drug Coated Balloon - Above-The-Knee - Prospective, Randomized, Multi-center, Single-blinded Study for the Treatment of Subjects Presenting with De Novo Occluded/Stenotic or Re-occluded/Restenotic Lesions of the Superficial Femoral or Popliteal Arteries Using Paclitaxel or Bare Percutaneous Transluminal Angioplasty Balloon Catheter
  • Stellarex Drug Coated Balloon - Above-The-Knee - Prospective, Single-arm, Global Multi-center Study to Evaluate Treatment of Obstructive Superficial Femoral Artery (SFA) and/or Popliteal Lesions with a Novel Paclitaxel-coated Percutaneous Angioplasty (PTA) Balloon and in In-Stent Restenosis (ILLUMENATE GLOBAL and ISR)
  • Stellarex Drug Coated Balloon - Above-The-Knee - Prospective, Single-arm, Multi-center, Pharmacokinetic Study to Evaluate Treatment of Obstructive Superficial Femoral Artery or Popliteal Lesions with a Novel Paclitaxel-coated Percutaneous Angioplasty Balloon
  • Stellarex Drug Coated Balloon - Above-The-Knee - Stellarex Vascular E-Registry
  • The Spectranetics Corp, Key Employees
  • The Spectranetics Corp, Other Locations
  • The Spectranetics Corp, Subsidiaries
  • Glossary
List of Figures
  • The Spectranetics Corp Pipeline Products by Equipment Type
  • The Spectranetics Corp Pipeline Products by Development Stage
  • The Spectranetics Corp Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Utah Medical Products Inc
  • Boston Scientific Corp
  • Abiomed Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll